These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2504465)

  • 1. Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.
    de la Piedra C; Torres R; Rapado A; Diaz Curiel M; Castro N
    Calcif Tissue Int; 1989 Jul; 45(1):58-60. PubMed ID: 2504465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can a determination of tartrate-resistant acid phosphatase predict postmenopausal loss of bone mass?
    Rico H; Arribas I; Villa LF; Casanova FJ; Hernández ER; Cortés-Prieto J
    Eur J Clin Invest; 2002 Apr; 32(4):274-8. PubMed ID: 11952813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.
    Rapado A; de la Piedra C; Torres R
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():30-4. PubMed ID: 2788062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals for two bone-derived enzyme activities in serum: bone isoenzyme of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TR-ACP).
    Panteghini M; Pagani F
    Clin Chem; 1989 Jan; 35(1):180-1. PubMed ID: 2910567
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydrochlorothiazide inhibits parathormone-stimulated increase in plasma tartrate-resistant acid phosphatase in mice.
    Broulik PD; Pacovský V
    Calcif Tissue Int; 1991 Jul; 49(1):51-2. PubMed ID: 1893295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral content in early-postmenopausal and postmenopausal osteoporotic women.
    Mazess RB
    Radiology; 1987 Oct; 165(1):289-91. PubMed ID: 3628787
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
    Stĕpán JJ; Lachmanová J; Straková M; Pacovský V
    Bone Miner; 1987 Nov; 3(2):177-83. PubMed ID: 3509796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of serum tartrate-resistant fluoride-sensitive acid phosphatase activity in evaluating bone turnover.
    Nakanishi M; Yoh K; Uchida K; Maruo S; Rai SK; Matsuoka A
    J Bone Miner Metab; 1999; 17(2):125-30. PubMed ID: 10340640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and normality: how to express the bone mineral content of lumbar vertebrae.
    Krølner B
    Clin Physiol; 1982 Apr; 2(2):139-46. PubMed ID: 7200850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological profile of tartrate-resistant acid phosphatase as a marker of bone resorption].
    Rico H; Iritia M; Arribas I; Revilla M
    Rev Esp Fisiol; 1990 Dec; 46(4):379-83. PubMed ID: 2099535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.
    Stĕpán JJ; Pospíchal J; Schreiber V; Kanka J; Mensík J; Presl J; Pacovský V
    Calcif Tissue Int; 1989 Nov; 45(5):273-80. PubMed ID: 2509014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD; Wahner HW; Mann KG; Riggs BL
    J Lab Clin Med; 1983 Oct; 102(4):470-6. PubMed ID: 6604769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral content in early-postmenopausal and postmenopausal osteoporotic women: comparison of measurement methods.
    Reinbold WD; Genant HK; Reiser UJ; Harris ST; Ettinger B
    Radiology; 1986 Aug; 160(2):469-78. PubMed ID: 3726129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
    Stĕpan JJ; Silinková-Málková E; Havránek T; Formánková J; Zichová M; Lachmanová J; Straková M; Broulik P; Pacovský V
    Clin Chim Acta; 1983 Sep; 133(2):189-200. PubMed ID: 6627682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.
    Iba K; Sonoda T; Takada J; Dohke T; Yamashita T
    J Bone Miner Metab; 2017 Mar; 35(2):171-176. PubMed ID: 26832388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced bone mass in daughters of women with osteoporosis.
    Seeman E; Hopper JL; Bach LA; Cooper ME; Parkinson E; McKay J; Jerums G
    N Engl J Med; 1989 Mar; 320(9):554-8. PubMed ID: 2915666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between bone mineral content and frequency of postmenopausal fractures.
    Jensen GF; Christiansen C; Boesen J; Hegedüs V; Transbøl I
    Acta Med Scand; 1983; 213(1):61-3. PubMed ID: 6829322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.
    Ismail F; Epstein S; Pacifici R; Droke D; Thomas SB; Avioli LV
    Calcif Tissue Int; 1986 Oct; 39(4):230-3. PubMed ID: 3098385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.